Translationale Neurodegeneration
Prof. Dr. Günter Höglinger
Leiter der Klinischen Forschung
am Standort München,
Gruppenleiter
am Standort München,
Gruppenleiter
Curriculum Vitae
| Degrees | |
|---|---|
| 2000-2007 | Habilitation, University of Marburg, Germany |
| 1992-2000 | MD, Universities of Regensburg, Würzburg and Marburg, Germany |
| 1991-1993 | Vor-Diplom (equivalent to BSc), Physics, University of Regensburg, Germany |
| Major previous appointments | |
|---|---|
| since 2017 | Head of the Interdisciplinary Clinical Trial Unit, DZNE Munich |
| since 2011 | Chair for Translational Neurodegeneration, TUM and DZNE Munich |
| since 2011 | Senior Consultant, Department for Neurology, TUM, Munich |
| 2011 | Deputy Director, Department of Neurology, Marburg University |
| 2009-2010 | Managing Senior Consultant, Department of Neurology, Marburg University |
| Activities in the Scientific Community / Professional Memberships | |
|---|---|
| since 2017 | President elect, German Parkinson Association (DPG) |
| since 2015 | Member of SABs of AbbVie, Asceneuron, BMS, Roche, Sanofi, UCB |
| since 2012 | Chair, International Movement Disorders Society-endorsed PSP Study Group |
| Honors and Awards | |
|---|---|
| 2017 | Dingebauer Prize for research in atypical Parkinson Syndromes, German Society for Neurology (DGN) |
| 2011-2016 | Heisenberg Professorship, German Research Council (DFG) |
| 2009 | First Price for „Innovative therapeutic strategies for neurodegenerative disorders“ Dr. Walter und Luise Freundlich-Foundation |
| 1994-1999 | Student Scholarship, Hanns Seidel Foundation |